Search - tctmd.com

Displaying 61 - 80 of 102

Sort: Relevancy | Date

News Daily News

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

April 03, 2015

News Daily News

BRIGHT Publicado: Bivalirudina Prolongada Reduce las Hemorragias y Controla la Trombosis Precoz del Stent en PCI Primarias

April 03, 2015

News Daily News

心力衰竭会使ACS后的结果恶化，阿哌沙班不能带来益处

Todd Neale

January 28, 2015

News Daily News

La IC Empeora los Resultados Post-SCA No observándose Beneficio alguno con Apixaban

Todd Neale

January 28, 2015

News Daily News

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Todd Neale

January 28, 2015

News Daily News

研究证实采用较新DES时支架内血栓形成和心肌梗死风险降低

Salynn Boyles

November 02, 2014

News Daily News

Un Estudio Confirma Menor Riesgo de Trombosis del Stent,IM con los Nuevos SLF

Salynn Boyles

November 02, 2014

News Daily News

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

Salynn Boyles

November 02, 2014

News Daily News

SCAAR: Menor Riesgo de Trombosis Precoz, Tardía del Stent con Nuevos SLF frente a SMD en el Manejo de Cuadros de STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

Presentation TCT 2013

The Case for Intravenous Cangrelor as the Preferred ADP Antagonist to Support Primary PCI

Presenter: Deepak Bhatt

October 30, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

News Daily News

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Caitlin E. Cox

April 19, 2013

News Daily News

Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA

Caitlin E. Cox

April 19, 2013

News Daily News

Una Escala Hemorrágica ayuda a los Médicos a Saber Qué Pacientes PCI son Más Aptos para recibir Bivalirudina

Caitlin E. Cox

March 09, 2013

News Daily News

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Caitlin E. Cox

March 09, 2013

News Daily News

Volume of Acute MI Cases Linked with Appropriate Medication Prescribing

L.A. McKeown

January 09, 2013

News Daily News

Relación entre el Volumen de Casos de IAM gestionados y una Correcta Prescripción de la Medicación

L.A. McKeown

January 09, 2013

Advertisement

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

BRIGHT Publicado: Bivalirudina Prolongada Reduce las Hemorragias y Controla la Trombosis Precoz del Stent en PCI Primarias

心力衰竭会使ACS后的结果恶化，阿哌沙班不能带来益处

La IC Empeora los Resultados Post-SCA No observándose Beneficio alguno con Apixaban

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

研究证实采用较新DES时支架内血栓形成和心肌梗死风险降低

Un Estudio Confirma Menor Riesgo de Trombosis del Stent,IM con los Nuevos SLF

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

SCAAR: Menor Riesgo de Trombosis Precoz, Tardía del Stent con Nuevos SLF frente a SMD en el Manejo de Cuadros de STEMI

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

The Case for Intravenous Cangrelor as the Preferred ADP Antagonist to Support Primary PCI

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA

Una Escala Hemorrágica ayuda a los Médicos a Saber Qué Pacientes PCI son Más Aptos para recibir Bivalirudina

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Volume of Acute MI Cases Linked with Appropriate Medication Prescribing

Relación entre el Volumen de Casos de IAM gestionados y una Correcta Prescripción de la Medicación

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content